Evaluation of 64Cu-Labeled New Anti-EGFR Antibody NCAB001 with Intraperitoneal Injection for Early PET Diagnosis of Pancreatic Cancer in Orthotopic Tumor-Xenografted Mice and Nonhuman Primates
Sign Up to like & getrecommendations! Published in 2021 at "Pharmaceuticals"
DOI: 10.3390/ph14100950
Abstract: Objectives: To improve the prognosis of pancreatic cancer, new imaging methods to identify tumor lesions at a size of read more here.
Keywords: 64cu labeled; pancreatic cancer; new anti; labeled new ... See more keywords